Internal Medicine, Medical Oncology · Rochester, MN
NPI
1356359111
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
89,278 services
Medicare patients, 2024
486
Average age 72
Drug cost, 2024
$1.7M
332 prescriptions
Company payments, 2025
$0
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S Block was code J9271 (injection, pembrolizumab, 1 mg), 13,300 times for 47 patients. In total Matthew S Block billed 89,278 services in 132 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,300 | 47 | $42.15 | $561K |
| J9299 Injection, nivolumab, 1 mg | Office | 7,840 | 16 | $24.59 | $193K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,650 | 47 | $0.11 | $831 |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,864 | 34 | $0.08 | $562 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 5,941 | 29 | $39.00 | $232K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 3,540 | 12 | $0.06 | $196 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 1,225 | 24 | $1.45 | $1,781 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,112 | 97 | $0.09 | $100 |
| J9305 Injection, pemetrexed, not otherwise specified, 10 mg | Office | 1,070 | 11 | $3.57 | $3,816 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 970 | 88 | $0.77 | $748 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 668 | 65 | $0.07 | $49.99 |
| 96375 Injection Administration | Office | 369 | 156 | $12.71 | $4,689 |
| J9045 Injection, carboplatin, 50 mg | Office | 290 | 33 | $2.86 | $831 |
| 96413 Chemotherapy Administration | Office | 276 | 231 | $105.16 | $29K |
| J9190 Injection, fluorouracil, 500 mg | Office | 245 | 26 | $2.32 | $569 |
By year: 2022 $1.3M for 67,703 services; 2023 $1.4M for 67,806 services; 2024 $2.3M for 89,278 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Block prescribed most often to Medicare patients was Mektovi (Binimetinib), with 39 prescriptions and refills. In total Matthew S Block wrote 332 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mektovi Binimetinib | 39 | 39 | Under 11 | $421K |
| Braftovi Encorafenib | 38 | 38 | Under 11 | $459K |
| Lynparza Olaparib | 27 | 27 | Under 11 | $345K |
| Prednisone Generic | 25 | 30 | Under 11 | $210 |
| Olanzapine Generic | 15 | 15 | Under 11 | $80.49 |
| Levothyroxine Sodium Generic | 14 | 34 | Under 11 | $89.22 |
| Prochlorperazine Maleate Generic | 14 | 14 | 12 | $148 |
| Hydrocortisone Generic | 11 | 11 | Under 11 | $492 |
Brand drugs: 148 claims; generic drugs: 184 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S Block $0 (- in general payments such as food, travel and fees) from 4 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.